AWAK Technologies raised $40 million to continue development of its wearable peritoneal dialysis device, which has received a breakthrough designation from the FDA.
The company will use the proceeds to complete the pivotal clinical trial of the AWAK PD device, strengthen the company’s research and development, and prepare for manufacturing and commercialization of the device, per a press release.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2020 Healio All Rights Reserved.